{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:36:08Z","timestamp":1790004968192,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hong Kong Blood Cancer Foundation"},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["81470369"],"award-info":[{"award-number":["81470369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.trsl.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T04:45:22Z","timestamp":1511498722000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Epigenetic silencing of EVL\/miR-342 in multiple myeloma"],"prefix":"10.1016","volume":"192","author":[{"given":"Zhenhai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-6022","authenticated-orcid":false,"given":"Kwan Yeung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey Chi-Fung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee-Joo","family":"Chng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chor Sang","family":"Chim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2017.11.005_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.trsl.2017.11.005_bib0015","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0020","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.11.005_bib0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2017.11.005_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2017.11.005_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2017.11.005_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2017.11.005_bib0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2017.11.005_bib0050","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth","volume":"19","author":"Leone","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0055","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1078-0432.CCR-14-1437","article-title":"miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.trsl.2017.11.005_bib0065","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2017.11.005_bib0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.694","article-title":"Hypermethylation of gene promoters in hematological neoplasia","volume":"20","author":"Chim","year":"2002","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0075","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2217\/epi.15.57","article-title":"DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma","volume":"7","author":"Wong","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.trsl.2017.11.005_bib0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/carcin\/bgr081","article-title":"MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1","volume":"32","author":"Wang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trsl.2017.11.005_bib0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2014.12.119","article-title":"miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-kappaB pathway","volume":"457","author":"Zhao","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2017.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3727\/096504017X14886485417426","article-title":"MicroRNA-342-3p inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting astrocyte-elevated gene-1 (AEG-1)","volume":"25","author":"Zhang","year":"2017","journal-title":"Oncol Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0100","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","article-title":"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant","volume":"102","author":"Blade","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1475-2867-13-122","article-title":"Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL","volume":"13","author":"Wong","year":"2013","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.trsl.2017.11.005_bib0115","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4161\/epi.27650","article-title":"Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age","volume":"9","author":"Kaz","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.trsl.2017.11.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019027","article-title":"Epigenetic inactivation of the miR-124-1 in haematological malignancies","volume":"6","author":"Wong","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2017.11.005_bib0125","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1158\/0008-5472.CAN-06-4218","article-title":"Genetic unmasking of an epigenetically silenced microRNA in human cancer cells","volume":"67","author":"Lujambio","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0130","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1182\/blood-2011-06-361022","article-title":"Epigenetic inactivation of the MIR34B\/C in multiple myeloma","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.11.005_bib0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgq033","article-title":"Epigenetic inactivation of the miR-34a in hematological malignancies","volume":"31","author":"Chim","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trsl.2017.11.005_bib0140","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4161\/cc.6.12.4408","article-title":"CpG island hypermethylation of tumor suppressor microRNAs in human cancer","volume":"6","author":"Lujambio","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2017.11.005_bib0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-4598-12-173","article-title":"Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia\u2014implications on constitutive activation of NFkappaB pathway","volume":"12","author":"Wang","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2017.11.005_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1755-8794-1-37","article-title":"An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma","volume":"1","author":"Ronchetti","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.trsl.2017.11.005_bib0155","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1038\/onc.2008.10","article-title":"Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer","volume":"27","author":"Grady","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2017.11.005_bib0160","article-title":"RNA polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2017.11.005_bib0165","article-title":"Epigenetic silencing of LPP\/miR-28 in multiple myeloma","author":"Li","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2011.08782.x","article-title":"Epigenetic silencing of MIR203 in multiple myeloma","volume":"154","author":"Wong","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-8722-6-16","article-title":"Epigenetic inactivation of the MIR129-2 in hematological malignancies","volume":"6","author":"Wong","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2017.11.005_bib0180","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2017.11.005_bib0185","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","article-title":"Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy","volume":"100","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2017.11.005_bib0190","doi-asserted-by":"crossref","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2017.11.005_bib0195","first-page":"513","article-title":"Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma","volume":"57","author":"Bandera","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0200","first-page":"3246","article-title":"Novel suppressor loci on chromosome 14q in primary bladder cancer","volume":"55","author":"Chang","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/35101031","article-title":"Two genetic hits (more or less) to cancer","volume":"1","author":"Knudson","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2017.11.005_bib0210","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1038\/ncomms7910","article-title":"DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis","volume":"6","author":"Pathania","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2017.11.005_bib0215","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3892\/ol.2014.2481","article-title":"Knockdown of DNA methyltransferase-1 inhibits proliferation and derepresses tumor suppressor genes in myeloma cells","volume":"8","author":"Zhou","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.trsl.2017.11.005_bib0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.leukres.2003.08.008","article-title":"Methylation profiling in multiple myeloma","volume":"28","author":"Chim","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.trsl.2017.11.005_bib0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"Walker","year":"2011","journal-title":"Blood"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524417303146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524417303146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T16:52:25Z","timestamp":1535215945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524417303146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":44,"alternative-id":["S1931524417303146"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2017.11.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic silencing of EVL\/miR-342 in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}